RayzeBio 소유권

주요 주주는 누구이며 내부자가 매수 또는 매도한 적이 있나요?

최근 내부자 거래

내부자 구매: 내부자가 지난 3개월 동안 판매한 것보다 더 많은 주식을 구입했는지 판단하기에는 데이터가 부족합니다.

주식의 희석: RYZB 최근 12개월 동안만 상장되었으며

상위 25 주주가 회사의 82.15%를 소유하고 있습니다.

소유권	이름	공유	현재 값	변경 %	포트폴리오 %
11.1%	Viking Global Investors LP	6,642,700	US$415.1m	0%	1.48%
8.61%	venBio LLC	5,158,162	US$322.3m	0%	48.43%
8.61%	Versant Venture Management, LLC	5,158,161	US$322.3m	0%	50.61%
6.73%	VR Adviser, LLC	4,030,471	US$251.9m	0.34%	11.29%
5.85%	Wellington Management Group LLP	3,504,409	US$219.0m	-9.59%	0.03%
4.04%	Sofinnova Investment, Inc.	2,419,528	US$151.2m	0%	7.44%
3.95%	OrbiMed Advisors LLC	2,365,213	US$147.8m	-9.82%	2.03%
3.1%	Redmile Group, LLC	1,857,706	US$116.1m	0%	4.07%
3.08%	Samsara BioCapital LLC	1,845,948	US$115.4m	0%	16.43%
2.71%	Kenneth Song	1,622,095	US$101.4m	0%	데이터 없음
2.28%	BlackRock, Inc.	1,368,838	US$85.5m	13,600%	데이터 없음
2.08%	Fairmount Funds Management LLC	1,245,929	US$77.9m	1.97%	7.71%
2.03%	Cormorant Asset Management, LP	1,213,478	US$75.8m	2.64%	3.08%
1.95%	The Vanguard Group, Inc.	1,169,984	US$73.1m	2,240%	데이터 없음
1.94%	PeptiDream Inc.	1,163,579	US$72.7m	0%	데이터 없음
1.77%	Hillhouse Investment Management, Ltd.	1,062,383	US$66.4m	-23.9%	0.4%
1.68%	Deerfield Management Company, L.P. Series C	1,006,126	US$62.9m	-13.2%	1.12%
1.57%	AllianceBernstein L.P.	938,877	US$58.7m	-24%	0.02%
1.45%	TCG Crossover Management, LLC	869,908	US$54.4m	0%	4.2%
1.3%	Ally Bridge Group	778,922	US$48.7m	0%	12.4%
1.3%	Sands Capital Ventures, LLC	778,922	US$48.7m	-34.9%	12.45%
1.29%	Laurion Capital Management LP	771,913	US$48.2m	-20.6%	1.7%
1.27%	Alpine Associates Management Inc.	762,900	US$47.7m	0%	2.8%
1.25%	Soleus Capital Management, L.P.	746,622	US$46.7m	65.5%	4.42%
1.24%	Perceptive Advisors LLC	744,056	US$46.5m	-4.22%	0.93%